Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 89

Cited In for PubMed (Select 11574398)

1.

Molecular docking studies of (4Z, 12Z)-cyclopentadeca-4, 12-dienone from Grewia hirsuta with some targets related to type 2 diabetes.

Natarajan A, Sugumar S, Bitragunta S, Balasubramanyan N.

BMC Complement Altern Med. 2015 Mar 20;15:73. doi: 10.1186/s12906-015-0588-5.

2.

Resistin and interleukin-6 exhibit racially-disparate expression in breast cancer patients, display molecular association and promote growth and aggressiveness of tumor cells through STAT3 activation.

Deshmukh SK, Srivastava SK, Bhardwaj A, Singh AP, Tyagi N, Marimuthu S, Dyess DL, Dal Zotto V, Carter JE, Singh S.

Oncotarget. 2015 May 10;6(13):11231-41.

4.

Adipokines levels are associated with the severity of liver disease in patients with alcoholic cirrhosis.

Kalafateli M, Triantos C, Tsochatzis E, Michalaki M, Koutroumpakis E, Thomopoulos K, Kyriazopoulou V, Jelastopulu E, Burroughs A, Lambropoulou-Karatza C, Nikolopoulou V.

World J Gastroenterol. 2015 Mar 14;21(10):3020-9. doi: 10.3748/wjg.v21.i10.3020.

5.

Adipokines and proinflammatory cytokines, the key mediators in the pathogenesis of nonalcoholic fatty liver disease.

Stojsavljević S, Gomerčić Palčić M, Virović Jukić L, Smirčić Duvnjak L, Duvnjak M.

World J Gastroenterol. 2014 Dec 28;20(48):18070-91. doi: 10.3748/wjg.v20.i48.18070.

6.

Obesity as a risk and severity factor in rheumatic diseases (autoimmune chronic inflammatory diseases).

Gremese E, Tolusso B, Gigante MR, Ferraccioli G.

Front Immunol. 2014 Nov 11;5:576. doi: 10.3389/fimmu.2014.00576. eCollection 2014. Review.

7.

Stratification of risk of death in severe acute alcoholic hepatitis using a panel of adipokines and cytokines.

Rachakonda V, Gabbert C, Raina A, Li H, Malik S, DeLany JP, Behari J.

Alcohol Clin Exp Res. 2014 Nov;38(11):2712-21. doi: 10.1111/acer.12558.

PMID:
25421508
8.

GW4064, a farnesoid X receptor agonist, upregulates adipokine expression in preadipocytes and HepG2 cells.

Xin XM, Zhong MX, Yang GL, Peng Y, Zhang YL, Zhu W.

World J Gastroenterol. 2014 Nov 14;20(42):15727-35. doi: 10.3748/wjg.v20.i42.15727.

9.

Resistin as a potential marker of renal disease in lupus nephritis.

Hutcheson J, Ye Y, Han J, Arriens C, Saxena R, Li QZ, Mohan C, Wu T.

Clin Exp Immunol. 2015 Mar;179(3):435-43. doi: 10.1111/cei.12473.

PMID:
25345756
10.

Maternal leptin, adiponectin, resistin, visfatin and tumor necrosis factor-alpha in normal and gestational diabetes.

Noureldeen AF, Qusti SY, Al-Seeni MN, Bagais MH.

Indian J Clin Biochem. 2014 Oct;29(4):462-70. doi: 10.1007/s12291-013-0394-0. Epub 2013 Oct 29.

PMID:
25298627
11.

Resistin might not be a risk factor for carotid artery atherosclerosis in elderly Chinese males.

Wang H, Wang YT, Fan L, Guo YT, Shi Y, Tao T, Zhao YX.

J Geriatr Cardiol. 2014 Sep;11(3):222-8. doi: 10.11909/j.issn.1671-5411.2014.03.016.

12.

Steroid replacement in primary adrenal failure does not appear to affect circulating adipokines.

Fichna M, Fichna P, Gryczyńska M, Czarnywojtek A, Żurawek M, Ruchała M.

Endocrine. 2015 Mar;48(2):677-85. doi: 10.1007/s12020-014-0388-6. Epub 2014 Aug 17.

13.

Elevated resistin levels induce central leptin resistance and increased atherosclerotic progression in mice.

Asterholm IW, Rutkowski JM, Fujikawa T, Cho YR, Fukuda M, Tao C, Wang ZV, Gupta RK, Elmquist JK, Scherer PE.

Diabetologia. 2014 Jun;57(6):1209-18. doi: 10.1007/s00125-014-3210-3. Epub 2014 Mar 13.

14.

Adenylyl cyclase-associated protein 1 is a receptor for human resistin and mediates inflammatory actions of human monocytes.

Lee S, Lee HC, Kwon YW, Lee SE, Cho Y, Kim J, Lee S, Kim JY, Lee J, Yang HM, Mook-Jung I, Nam KY, Chung J, Lazar MA, Kim HS.

Cell Metab. 2014 Mar 4;19(3):484-97. doi: 10.1016/j.cmet.2014.01.013.

15.

The relationship between hepatic resistin overexpression and inflammation in patients with nonalcoholic steatohepatitis.

Shen C, Zhao CY, Wang W, Wang YD, Sun H, Cao W, Yu WY, Zhang L, Ji R, Li M, Gao J.

BMC Gastroenterol. 2014 Feb 23;14:39. doi: 10.1186/1471-230X-14-39.

16.

What we talk about when we talk about fat.

Rosen ED, Spiegelman BM.

Cell. 2014 Jan 16;156(1-2):20-44. doi: 10.1016/j.cell.2013.12.012. Review.

17.

Resistin in rodents and humans.

Park HK, Ahima RS.

Diabetes Metab J. 2013 Dec;37(6):404-14. doi: 10.4093/dmj.2013.37.6.404.

18.

Resistin increases monolayer permeability of human coronary artery endothelial cells.

Jamaluddin MS, Yan S, Lü J, Liang Z, Yao Q, Chen C.

PLoS One. 2013 Dec 27;8(12):e84576. doi: 10.1371/journal.pone.0084576. eCollection 2013.

19.

Increased resistin serum concentrations in patientswith type 1 diabetes mellitus.

Geyikli I, Keskin M, Kör Y, Akan M.

J Clin Res Pediatr Endocrinol. 2013 Sep 10;5(3):189-93. doi: 10.4274/Jcrpe.1072.

20.

Human resistin in chemotherapy-induced heart failure in humanized male mice and in women treated for breast cancer.

Schwartz DR, Briggs ER, Qatanani M, Sawaya H, Sebag IA, Picard MH, Scherrer-Crosbie M, Lazar MA.

Endocrinology. 2013 Nov;154(11):4206-14. doi: 10.1210/en.2013-1399. Epub 2013 Aug 27.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk